NCT07791004

Brief Summary

Persistent non-dental orofacial pain is common yet poorly characterised, and its pathophysiology remains largely unknown. Two clinically similar entities are distinguished: post-traumatic trigeminal neuropathic pain (PTNP), in which peripheral nerve damage is demonstrable, and persistent idiopathic facial pain (PIFP), in which peripheral findings are typically absent - pointing to an altered central processing of trigeminal nociceptive input. This monocentric study characterises the peripheral and central mechanisms of PIFP by comparing PIFP patients with age- and sex-matched healthy controls using a combination of non-invasive peripheral and central approaches. The study comprises two work packages. The peripheral work package uses quantitative sensory testing (standardised DFNS protocol) to test the hypothesis that PIFP patients retain an intact peripheral nervous system. The central work package uses functional MRI with standardised trigemino-nociceptive stimulation to characterise brainstem network dynamics, testing the hypothesis that PIFP patients exhibit a central trigeminal processing disturbance at the brainstem level. In PIFP patients, the functional MRI is repeated before and after a local-anaesthetic nerve block in the pain area, additionally distinguishing patients whose pain is completely abolished by the block from those with persistent pain despite it. The overarching aim is to characterise the pathophysiological basis of PIFP and thereby advance the mechanistic understanding of persistent orofacial pain.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
39mo left

Started Sep 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2029

4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2029

Last Updated

August 27, 2026

Status Verified

August 1, 2026

Enrollment Period

2.8 years

First QC Date

August 18, 2026

Last Update Submit

August 25, 2026

Conditions

Keywords

PIFPfMRIatypical facial painnerve blocklocal anesthesia

Outcome Measures

Primary Outcomes (2)

  • Difference in brain functional neuroimaging response to standardized trigemino-nociceptive stimulation between PIFP patients HC

    BOLD signal change (contrast estimates, arbitrary units) during standardized trigemino-nociceptive stimulation versus baseline, compared between PIFP patients and HC in a priori defined regions of interest and at whole-brain level.

    Baseline (MRI session before local anesthesia)

  • Difference in brain activation before versus after the local-anesthetic nerve block, and between complete responders and non-responders

    BOLD signal change (contrast estimates, arbitrary units) during standardized trigemino-nociceptive stimulation, compared within participants before versus after the local-anesthetic nerve block, and between participants whose pain is completely abolished by the block and those with persistent pain despite the block

    Pre-block MRI at baseline and post-block MRI, both on the same day 1

Secondary Outcomes (1)

  • Comparison of deep phenotyping and quantitative sensory testing (QST) parameters between the study cohorts (PIFP versus HC).

    Baseline (single assessment before local anesthesia)

Study Arms (2)

Patients with persistent idiopathic facial pain (PIFP)

Patients with persistent idiopathic facial pain

Age- and sex-matched healthy controls (HC)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with PIFP will be recruited from the headache/facial pain outpatient clinic of the University Medical Center Hamburg-Eppendorf

You may qualify if:

  • Healthy controls: written informed consent.
  • PIFP cohort: written informed consent, and a diagnosis of PIFP according to the ICHD-3 and ICOP diagnostic criteria.

You may not qualify if:

  • Contraindication to MR scanning
  • Anxiety disorders, including claustrophobia
  • Other somatic diseases, including other pain disorders
  • Other primary headache disorders and medication-overuse headache
  • Skin lesion , infection, or scarring at the stimulation sites preventing safe electrode placement
  • Healthy volunteers: any history of persistent pain or primary headache, including in first-degree relatives
  • History of psychiatric disease and/or addiction
  • Pregnancy or lactation
  • Any regular medication; in PIFP patients, occasional acute analgesic use (NSAID, fewer than 8 days per month) is permitted
  • Use of acute analgesic within 24 hours before the experiment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Center Hamburg-Eppendorf

Hamburg, 20246, Germany

Location

Related Publications (3)

  • Ziegeler C, Schulte LH, May A. Altered trigeminal pain processing on brainstem level in persistent idiopathic facial pain. Pain. 2021 May 1;162(5):1374-1378. doi: 10.1097/j.pain.0000000000002126.

    PMID: 33110030BACKGROUND
  • Mehnert J, Basedau H, Sturm LM, Nielsen T, Jensen RH, May A. Functional brainstem representations of the human trigeminal cervical complex. Cephalalgia. 2023 May;43(5):3331024231174862. doi: 10.1177/03331024231174862.

    PMID: 37203351BACKGROUND
  • May A, Ciancia V, Basedau H. Visualizing nociplastic pain: functional hyperexcitability in neuropathic and idiopathic facial pain syndromes. J Headache Pain. 2025 Oct 13;26(1):211. doi: 10.1186/s10194-025-02133-w.

    PMID: 41083924BACKGROUND

Study Officials

  • Arne May, MD, PhD

    Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Arne May, MD, PhD

CONTACT

Kuan-Po Peng, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Associate

Study Record Dates

First Submitted

August 18, 2026

First Posted

August 27, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

June 30, 2029

Study Completion (Estimated)

October 31, 2029

Last Updated

August 27, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared with other researchers. Data are collected and analyzed in pseudonymized form, and results will be reported and published only in aggregated, anonymized form that does not permit identification of individual participants. The pseudonymization key is held exclusively by the study leadership and is deleted as soon as the research purpose allows. Consistent with the informed consent obtained from participants and the approved data protection concept, no de-identified individual-level datasets will be made available externally.

Locations